{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:34:01Z","timestamp":1777365241782,"version":"3.51.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04080-0","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:34:45Z","timestamp":1777361685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Formulation of treatment protocol for ocular surface squamous neoplasia"],"prefix":"10.1007","volume":"46","author":[{"given":"Seyed-Hashem","family":"Daryabari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Aghamollaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Rahim","family":"Hassanpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed Morteza","family":"Hosseini Imeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Sepandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Raei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"6","key":"4080_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/s0039-6257(05)80054-2","volume":"39","author":"GA Lee","year":"1995","unstructured":"Lee GA, Hirst LW (1995) Ocular surface squamous neoplasia. Surv Ophthalmol 39(6):429\u2013450. https:\/\/doi.org\/10.1016\/s0039-6257(05)80054-2. (Epub 1995\/05\/01)","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"4080_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/00003226-200310000-00015","volume":"22","author":"S Basti","year":"2003","unstructured":"Basti S, Macsai MS (2003) Ocular surface squamous neoplasia: a review. Cornea 22(7):687\u2013704. https:\/\/doi.org\/10.1097\/00003226-200310000-00015. (Epub 2003\/09\/26)","journal-title":"Cornea"},{"key":"4080_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2147\/opth.s87308","volume":"9","author":"RE Domingo","year":"2015","unstructured":"Domingo RE, Manganip LE, Castro RM (2015) Tumors of the eye and ocular adnexa at the Philippine Eye Research Institute: a 10-year review. Clin Ophthalmol (Auckland, NZ) 9:1239\u20131247. https:\/\/doi.org\/10.2147\/opth.s87308. (Epub 2015\/07\/18)","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"4","key":"4080_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.amjoto.2019.05.013","volume":"40","author":"NB Abt","year":"2019","unstructured":"Abt NB, Zhao J, Huang Y, Eghrari AO (2019) Prognostic factors and survival for malignant conjunctival melanoma and squamous cell carcinoma over four decades. Am J Otolaryngol 40(4):577\u2013582. https:\/\/doi.org\/10.1016\/j.amjoto.2019.05.013. (Epub 2019\/05\/22)","journal-title":"Am J Otolaryngol"},{"issue":"2","key":"4080_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/aam.aam_37_18","volume":"18","author":"SG Habib","year":"2019","unstructured":"Habib SG, Lawan A, Victoria P (2019) Clinicopathologic presentation of malignant orbito-ocular tumors in Kano, Nigeria: a prospective multicenter study. Ann Afr Med 18(2):86\u201391. https:\/\/doi.org\/10.4103\/aam.aam_37_18. (Epub 2019\/05\/10)","journal-title":"Ann Afr Med"},{"issue":"219","key":"4080_CR6","first-page":"352","volume":"57","author":"SU Kafle","year":"2019","unstructured":"Kafle SU, Singh M, Kafle PA, Kc B, Yadav SK, Kc AK et al (2019) Prevalence of histopathologically diagnosed ophthalmic neoplastic lesion among ophthalmic biopsies in a pathology laboratory of tertiary hospital of Nepal. JNMA; J of the Nepal Med Assoc 57(219):352\u2013356","journal-title":"JNMA; J of the Nepal Med Assoc"},{"issue":"4","key":"4080_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/meajo.MEAJO_275_19","volume":"27","author":"S Kaliki","year":"2020","unstructured":"Kaliki S, Das AV (2020) Ocular and periocular tumors in India: an EyeSmart electronic medical record analysis of 9633 cases from a referral center. Middle East Afr J Ophthalmol 27(4):199\u2013203. https:\/\/doi.org\/10.4103\/meajo.MEAJO_275_19. (Epub 2021\/04\/06)","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"24","key":"4080_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3126\/nepjoph.v12i2.28364","volume":"12","author":"N Pant","year":"2020","unstructured":"Pant N, Shrestha GB, Joshi SN, Bhatta S (2020) Profile of ophthalmic tumors in adult Nepalese population in central Nepal. Nepalese J Ophthalmol 12(24):270\u2013280. https:\/\/doi.org\/10.3126\/nepjoph.v12i2.28364. (Epub 2021\/05\/13)","journal-title":"Nepalese J Ophthalmol"},{"issue":"1","key":"4080_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2022-000977","volume":"7","author":"FW Sinyiza","year":"2022","unstructured":"Sinyiza FW, Chisale MRO, Kayira AB, Chimbatata CS, Kaseka PU, Kamudumuli P et al (2022) Histopathological profile of orbito-ocular cancers at a tertiary hospital in Northern Malawi: a retrospective cross-sectional study. BMJ Open Ophthalmol 7(1):e000977. https:\/\/doi.org\/10.1136\/bmjophth-2022-000977. (Epub 2022\/04\/12)","journal-title":"BMJ Open Ophthalmol"},{"issue":"12","key":"4080_CR10","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/tmi.12792","volume":"21","author":"S Gichuhi","year":"2016","unstructured":"Gichuhi S, Macharia E, Kabiru J, Zindamoyen AM, Rono H, Ollando E et al (2016) Risk factors for ocular surface squamous neoplasia in Kenya: a case-control study. Trop Med Int Health 21(12):1522\u20131530. https:\/\/doi.org\/10.1111\/tmi.12792. (Epub 2016\/10\/25)","journal-title":"Trop Med Int Health"},{"issue":"2","key":"4080_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000511610","volume":"7","author":"P Julius","year":"2021","unstructured":"Julius P, Siyumbwa SN, Moonga P, Maate F, Kaile T, Kang G et al (2021) Clinical and pathologic presentation of primary ocular surface tumors among Zambians. Ocul Oncol Pathol 7(2):108\u2013120. https:\/\/doi.org\/10.1159\/000511610. (Epub 2021\/04\/20.)","journal-title":"Ocul Oncol Pathol"},{"issue":"5","key":"4080_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1590\/s1516-31802000000500003","volume":"118","author":"MA Palazzi","year":"2000","unstructured":"Palazzi MA, Erwenne CM, Villa LL (2000) Detection of human papillomavirus in epithelial lesions of the conjunctiva. Sao Paulo Med J 118(5):125\u2013130. https:\/\/doi.org\/10.1590\/s1516-31802000000500003. (Epub 2000\/10\/06.)","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"4080_CR13","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/s0161-6420(01)00991-5","volume":"109","author":"IU Scott","year":"2002","unstructured":"Scott IU, Karp CL, Nuovo GJ (2002) Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmol 109(3):542\u2013547. https:\/\/doi.org\/10.1016\/s0161-6420(01)00991-5. (Epub 2002\/03\/05.)","journal-title":"Ophthalmol"},{"issue":"6","key":"4080_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1309\/t189-uwwv-b71m-9vrc","volume":"122","author":"P Moubayed","year":"2004","unstructured":"Moubayed P, Mwakyoma H, Schneider DT (2004) High frequency of human papillomavirus 6\/11, 16, and 18 infections in precancerous lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania. Am J Clin Pathol 122(6):938\u2013943. https:\/\/doi.org\/10.1309\/t189-uwwv-b71m-9vrc. (Epub 2004\/11\/13.)","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"4080_CR15","first-page":"707","volume":"49","author":"F Asadi-Amoli","year":"2011","unstructured":"Asadi-Amoli F, Heidari AB, Jahanzad I, Jabbarvand M (2011) Detection of human papillomavirus in squamous cell carcinoma of conjunctiva by nested PCR: a case control study in Iran. Acta Med Iran 49(11):707\u2013714 (Epub 2011\/12\/02. PubMed PMID: 22131239.)","journal-title":"Acta Med Iran"},{"issue":"13","key":"4080_CR16","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.1167\/iovs.13-13140","volume":"54","author":"M Woods","year":"2013","unstructured":"Woods M, Chow S, Heng B, Glenn W, Whitaker N, Waring D et al (2013) Detecting human papillomavirus in ocular surface diseases. Invest Ophthalmol Vis Sci 54(13):8069\u20138078. https:\/\/doi.org\/10.1167\/iovs.13-13140. (Epub 2013\/11\/21.)","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4080_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.21149\/12796","volume":"64","author":"P De La Parra-Colin","year":"2022","unstructured":"De La Parra-Colin P, Pichardo-Bahena R, M\u00e9ndez-Mart\u00ednez R, Garc\u00eda-Carranc\u00e1 A, Barrientos-Gutierrez T, Santamar\u00eda-Olmedo M et al (2022) Association of high-risk human papillomavirus with ocular surface squamous neoplasia: a case-control study in Mexico. Salud Publica de Mex 64(2):209\u2013217","journal-title":"Salud Publica de Mex"},{"issue":"1","key":"4080_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-019-0138-1","volume":"6","author":"LM Smith","year":"2019","unstructured":"Smith LM, Lamba S, Karp CL, Galor A (2019) Epidemiology of ocular surface squamous neoplasia in veterans: a retrospective case-control study. Eye Vis 6(1):14. https:\/\/doi.org\/10.1186\/s40662-019-0138-1","journal-title":"Eye Vis"},{"issue":"10","key":"4080_CR19","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1007\/s10792-021-01894-y","volume":"41","author":"O Fasina","year":"2021","unstructured":"Fasina O (2021) Ocular surface squamous neoplasia at a tertiary eye facility, Southwestern Nigeria: a 10-year review. Int Ophthalmol 41(10):3325\u20133331. https:\/\/doi.org\/10.1007\/s10792-021-01894-y. (Epub 2021\/05\/21.)","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4080_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02340-y","volume":"22","author":"N Tananuvat","year":"2022","unstructured":"Tananuvat N, Niparugs M, Wiwatwongwana D, Lertprasertsuk N, Mahanupap P (2022) Ocular surface squamous neoplasia in Northern Thailand: a 16-year review. BMC Ophthalmol 22(1):121. https:\/\/doi.org\/10.1186\/s12886-022-02340-y. (Epub 2022\/03\/14.)","journal-title":"BMC Ophthalmol"},{"key":"4080_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajo.2016.09.034","volume":"173","author":"CL Shields","year":"2017","unstructured":"Shields CL, Alset AE, Boal NS, Casey MG, Knapp AN, Sugarman JA et al (2017) Conjunctival tumors in 5002 cases. Comparative analysis of benign versus malignant counterparts. The 2016 James D. Allen lecture. Am J Ophthalmol 173:106\u2013133. https:\/\/doi.org\/10.1016\/j.ajo.2016.09.034. (Epub 2016\/10\/12.)","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"4080_CR22","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/bjophthalmol-2017-311530","volume":"102","author":"LA Dalvin","year":"2018","unstructured":"Dalvin LA, Salom\u00e3o DR, Patel SV (2018) Population-based incidence of conjunctival tumours in Olmsted County, Minnesota. Br J Ophthalmol 102(12):1728\u20131734. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311530. (Epub 2018\/03\/08.)","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4080_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/iio.0000000000000174","volume":"57","author":"AA Nanji","year":"2017","unstructured":"Nanji AA, Mercado C, Galor A, Dubovy S, Karp CL (2017) Updates in ocular surface tumor diagnostics. Int Ophthalmol Clin 57(3):47\u201362. https:\/\/doi.org\/10.1097\/iio.0000000000000174. (Epub 2017\/06\/08.)","journal-title":"Int Ophthalmol Clin"},{"key":"4080_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.yaoo.2019.04.006","volume":"4","author":"A Polski","year":"2019","unstructured":"Polski A, Amin S, Patel S, Berry JL (2019) Biopsy techniques in ocular oncology. Adv Ophthalmol Optom 4:101\u2013128","journal-title":"Adv Ophthalmol Optom"},{"issue":"3","key":"4080_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1586\/eop.13.16","volume":"8","author":"M Tsatsos","year":"2013","unstructured":"Tsatsos M, Karp CL (2013) Modern management of ocular surface squamous neoplasia. Expert Rev Ophthalmol 8(3):287\u2013295","journal-title":"Expert Rev Ophthalmol"},{"issue":"3","key":"4080_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/0301-4738.156912","volume":"63","author":"SG Honavar","year":"2015","unstructured":"Honavar SG, Manjandavida FP (2015) Tumors of the ocular surface: A review. Indian J Ophthalmol 63(3):187\u2013203. https:\/\/doi.org\/10.4103\/0301-4738.156912. (Epub 2015\/05\/15.)","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"4080_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yaoo.2018.04.007","volume":"3","author":"C Greer","year":"2018","unstructured":"Greer C, Polski A, Berry JL (2018) Topical chemotherapy and the evolving role of the biopsy for ocular surface squamous neoplasia. Adv Ophthalmol Optom 3(1):115\u2013137","journal-title":"Adv Ophthalmol Optom"},{"issue":"3","key":"4080_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2015.10.043","volume":"123","author":"CS Moon","year":"2016","unstructured":"Moon CS, Nanji AA, Galor A, McCollister KE, Karp CL (2016) Surgical versus medical treatment of ocular surface squamous neoplasia: A cost comparison. Ophthalmol 123(3):497\u2013504. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.043. (Epub 2015\/12\/22.)","journal-title":"Ophthalmol"},{"issue":"6","key":"4080_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archopht.1997.01100150810025","volume":"115","author":"JA Shields","year":"1997","unstructured":"Shields JA, Shields CL, De Potter P (1997) Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch of Ophthalmol (Chicago, Ill\u202f: 1960) 115(6):808\u2013815. https:\/\/doi.org\/10.1001\/archopht.1997.01100150810025. (Epub 1997\/06\/01.)","journal-title":"Arch of Ophthalmol (Chicago, Ill : 1960)"},{"issue":"4","key":"4080_CR30","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/0002-9394(72)90831-8","volume":"74","author":"N Sanders","year":"1972","unstructured":"Sanders N, Bedotto C (1972) Recurrent carcinoma in situ of the conjunctiva and cornea (Bowen\u2019s disease). Am J Ophthalmol 74(4):688\u2013693. https:\/\/doi.org\/10.1016\/0002-9394(72)90831-8. (Epub 1972\/10\/01.)","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4080_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1755-3768.1982.tb05791.x","volume":"60","author":"T Hirotakahashi","year":"1982","unstructured":"Hirotakahashi T (1982) Bowen\u2019s disease at the limbus. Acta Ophthalmol 60(1):147\u2013155","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"4080_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0002-9394(14)78306-0","volume":"95","author":"FT Fraunfelder","year":"1983","unstructured":"Fraunfelder FT, Wingfield D (1983) Management of intraepithelial conjunctival tumors and squamous cell carcinomas. Am J Ophthalmol 95(3):359\u2013363. https:\/\/doi.org\/10.1016\/s0002-9394(14)78306-0. (Epub 1983\/03\/01.)","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4080_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0002-9394(89)90655-7","volume":"107","author":"G Peksayar","year":"1989","unstructured":"Peksayar G, Soyt\u00fcrk MK, Demiryont M (1989) Long-term results of cryotherapy on malignant epithelial tumors of the conjunctiva. Am J Ophthalmol 107(4):337\u2013340. https:\/\/doi.org\/10.1016\/0002-9394(89)90655-7. (Epub 1989\/04\/15.)","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4080_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1442-9071.1997.tb01514.x","volume":"25","author":"GA Lee","year":"1997","unstructured":"Lee GA, Hirst LW (1997) Retrospective study of ocular surface squamous neoplasia. Aust N Z J Ophthalmol 25(4):269\u2013276. https:\/\/doi.org\/10.1111\/j.1442-9071.1997.tb01514.x","journal-title":"Aust N Z J Ophthalmol"},{"issue":"3","key":"4080_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/s0161-6420(97)30287-5","volume":"104","author":"G Tabin","year":"1997","unstructured":"Tabin G, Levin S, Snibson G, Loughnan M, Taylor H (1997) Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmol 104(3):485\u2013492. https:\/\/doi.org\/10.1016\/s0161-6420(97)30287-5. (Epub 1997\/03\/01.)","journal-title":"Ophthalmol"},{"issue":"3","key":"4080_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00003226-200005000-00004","volume":"19","author":"S Sudesh","year":"2000","unstructured":"Sudesh S, Rapuano CJ, Cohen EJ, Eagle RC Jr., Laibson PR (2000) Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea 19(3):278\u2013283. https:\/\/doi.org\/10.1097\/00003226-200005000-00004. (Epub 2000\/06\/01.)","journal-title":"Cornea"},{"issue":"6","key":"4080_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/bjo.86.6.640","volume":"86","author":"EM Espana","year":"2002","unstructured":"Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC (2002) Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol 86(6):640\u2013645. https:\/\/doi.org\/10.1136\/bjo.86.6.640. (Epub 2002\/05\/30.)","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4080_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/sj.eye.6700331","volume":"17","author":"G Peksayar","year":"2003","unstructured":"Peksayar G, Altan-Yaycioglu R, Onal S (2003) Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours. Eye (Lond) 17(2):228\u2013232. https:\/\/doi.org\/10.1038\/sj.eye.6700331. (Epub 2003\/03\/18.)","journal-title":"Eye (Lond)"},{"issue":"5","key":"4080_CR39","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ophtha.2013.11.017","volume":"121","author":"AA Nanji","year":"2014","unstructured":"Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL (2014) Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Ophthalmol 121(5):994\u20131000. https:\/\/doi.org\/10.1016\/j.ophtha.2013.11.017. (Epub 2014\/01\/15.)","journal-title":"Ophthalmol"},{"issue":"9","key":"4080_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/eye.2014.148","volume":"28","author":"M Palamar","year":"2014","unstructured":"Palamar M, Kaya E, Egrilmez S, Akalin T, Yagci A (2014) Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye (Lond) 28(9):1131\u20131135. https:\/\/doi.org\/10.1038\/eye.2014.148. (Epub 2014\/07\/06.)","journal-title":"Eye (Lond)"},{"issue":"2","key":"4080_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajo.2015.04.027","volume":"160","author":"AS Li","year":"2015","unstructured":"Li AS, Shih CY, Rosen L, Steiner A, Milman T, Udell IJ (2015) Recurrence of ocular surface squamous neoplasia treated with excisional biopsy and cryotherapy. Am J Ophthalmol 160(2):213\u20139.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.04.027. (Epub 2015\/04\/29.)","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"4080_CR42","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1007\/s00417-021-05264-3","volume":"259","author":"G Savino","year":"2021","unstructured":"Savino G, Cuffaro G, Maceroni M, Pagliara MM, Sammarco MG, Giraldi L et al (2021) Advanced ocular surface squamous cell carcinoma (OSSC): long-term follow-up. Graefes Arch Clin Exp Ophthalmol 259(11):3437\u20133443. https:\/\/doi.org\/10.1007\/s00417-021-05264-3. (Epub 2021\/07\/21.)","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"4080_CR43","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/s0161-6420(00)00389-4","volume":"107","author":"RP Yeatts","year":"2000","unstructured":"Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA (2000) 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthal 107(12):2190\u20132195. https:\/\/doi.org\/10.1016\/s0161-6420(00)00389-4. (Epub 2000\/11\/30.)","journal-title":"Ophthal"},{"issue":"1","key":"4080_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00003226-200201000-00003","volume":"21","author":"BA Schechter","year":"2002","unstructured":"Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE (2002) Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea 21(1):6\u201311. https:\/\/doi.org\/10.1097\/00003226-200201000-00003. (Epub 2002\/01\/24.)","journal-title":"Cornea"},{"issue":"8","key":"4080_CR45","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.ophtha.2007.10.039","volume":"115","author":"BA Schechter","year":"2008","unstructured":"Schechter BA, Koreishi AF, Karp CL, Feuer W (2008) Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmol 115(8):1291\u20136, 6.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2007.10.039. (Epub 2008\/01\/12.)","journal-title":"Ophthalmol"},{"issue":"1","key":"4080_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.survophthal.2013.01.003","volume":"59","author":"BF Fernandes","year":"2014","unstructured":"Fernandes BF, Nikolitch K, Coates J, Novais G, Odashiro A, Odashiro PP et al (2014) Local chemotherapeutic agents for the treatment of ocular malignancies. Surv Ophthalmol 59(1):97\u2013114. https:\/\/doi.org\/10.1016\/j.survophthal.2013.01.003. (Epub 2013\/10\/12.)","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"4080_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/iio.0000000000000050","volume":"55","author":"J Pe'er","year":"2015","unstructured":"Pe\u2019er J (2015) Ocular surface squamous neoplasia: evidence for topical chemotherapy. Int Ophthalmol Clin 55(1):9\u201321. https:\/\/doi.org\/10.1097\/iio.0000000000000050. (Epub 2014\/12\/02.)","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"4080_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/eye.2012.241","volume":"27","author":"C Stannard","year":"2013","unstructured":"Stannard C, Sauerwein W, Maree G, Lecuona K (2013) Radiotherapy for ocular tumours. Eye (Lond) 27(2):119\u2013127. https:\/\/doi.org\/10.1038\/eye.2012.241. (Epub 2012\/11\/24.)","journal-title":"Eye (Lond)"},{"issue":"1","key":"4080_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40123-019-00225-w","volume":"9","author":"VML Cohen","year":"2020","unstructured":"Cohen VML, O\u2019Day RF (2020) Management issues in conjunctival tumours: ocular surface squamous neoplasia. Ophthalmol Ther 9(1):181\u2013190. https:\/\/doi.org\/10.1007\/s40123-019-00225-w. (Epub 2019\/11\/25.)","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"4080_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2021-000842","volume":"6","author":"OP Alvarez","year":"2021","unstructured":"Alvarez OP, Zein M, Galor A, Karp CL (2021) Management of ocular surface squamous neoplasia: Bowman Club Lecture 2021. BMJ Open Ophthalmol 6(1):e000842. https:\/\/doi.org\/10.1136\/bmjophth-2021-000842. (Epub 2021\/08\/17.)","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"4080_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/17469899.2018.1417840","volume":"13","author":"ON Klefter","year":"2018","unstructured":"Klefter ON, Rasmussen MLR, Toft PB, Heegaard S (2018) Therapeutic options for conjunctival neoplasia. Expert Rev Ophthalmol 13(1):17\u201331","journal-title":"Expert Rev Ophthalmol"},{"issue":"6","key":"4080_CR52","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/08820538.2024.2432908","volume":"40","author":"SV Vempuluru","year":"2025","unstructured":"Vempuluru SV, Luthra A, Sinha P, Gavara S, Kaliki S (2025) Nodulo-ulcerative ocular surface squamous neoplasia in 27 patients: clinical presentation, management and outcomes. Semin Ophthalmol 40(6):501\u2013507. https:\/\/doi.org\/10.1080\/08820538.2024.2432908","journal-title":"Semin Ophthalmol"},{"key":"4080_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001031","author":"S Kaliki","year":"2017","unstructured":"Kaliki S, Freitag SK, Chodosh J (2017) Nodulo-ulcerative ocular surface squamous neoplasia in 6 patients: a rare presentation. Cornea. https:\/\/doi.org\/10.1097\/ICO.0000000000001031","journal-title":"Cornea"},{"issue":"6","key":"4080_CR54","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/s0161-6420(01)00577-2","volume":"108","author":"CL Karp","year":"2001","unstructured":"Karp CL, Moore JK, Rosa RH Jr. (2001) Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmol 108(6):1093\u20131098. https:\/\/doi.org\/10.1016\/s0161-6420(01)00577-2. (Epub 2001\/05\/31.)","journal-title":"Ophthalmol"},{"issue":"3","key":"4080_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/00003495-200666030-00005","volume":"66","author":"LM Abraham","year":"2006","unstructured":"Abraham LM, Selva D, Casson R, Leibovitch I (2006) Mitomycin: clinical applications in ophthalmic practice. Drugs 66(3):321\u2013340. https:\/\/doi.org\/10.2165\/00003495-200666030-00005. (Epub 2006\/03\/11.)","journal-title":"Drugs"},{"issue":"2","key":"4080_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1442-6404.2002.00497.x","volume":"30","author":"M Daniell","year":"2002","unstructured":"Daniell M, Maini R, Tole D (2002) Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin Exp Ophthalmol 30(2):94\u201398. https:\/\/doi.org\/10.1046\/j.1442-6404.2002.00497.x. (Epub 2002\/03\/12.)","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"4080_CR57","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/s0002-9394(02)01400-9","volume":"133","author":"CL Shields","year":"2002","unstructured":"Shields CL, Naseripour M, Shields JA (2002) Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 133(5):601\u2013606. https:\/\/doi.org\/10.1016\/s0002-9394(02)01400-9. (Epub 2002\/05\/07.)","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4080_CR58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/01.ico.0000148314.86557.6a","volume":"24","author":"P Prabhasawat","year":"2005","unstructured":"Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W et al (2005) Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea 24(4):443\u2013448. https:\/\/doi.org\/10.1097\/01.ico.0000148314.86557.6a. (Epub 2005\/04\/15.)","journal-title":"Cornea"},{"issue":"5","key":"4080_CR59","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ophtha.2006.09.026","volume":"114","author":"LW Hirst","year":"2007","unstructured":"Hirst LW (2007) Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. Ophthalmol 114(5):976\u2013982. https:\/\/doi.org\/10.1016\/j.ophtha.2006.09.026. (Epub 2007\/01\/24.)","journal-title":"Ophthalmol"},{"key":"4080_CR60","unstructured":"Eghtedari M (2008) Mitomycin C in recurrent or extensive ocular surface neoplasia. UHOD: Intern J of Hematol & Oncol\/Uluslar Hematol Onkol Derg 18(1)"},{"issue":"4","key":"4080_CR61","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/IOP.0b013e3181ac4c39","volume":"25","author":"PL Ballalai","year":"2009","unstructured":"Ballalai PL, Erwenne CM, Martins MC, Lowen MS, Barros JN (2009) Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ophthalmic Plast Reconstr Surg 25(4):296\u2013299. https:\/\/doi.org\/10.1097\/IOP.0b013e3181ac4c39. (Epub 2009\/07\/21.)","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"4080_CR62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/bjo.2009.168294","volume":"94","author":"A Gupta","year":"2010","unstructured":"Gupta A, Muecke J (2010) Treatment of ocular surface squamous neoplasia with Mitomycin C. Br J Ophthalmol 94(5):555\u2013558. https:\/\/doi.org\/10.1136\/bjo.2009.168294. (Epub 2010\/05\/08.)","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4080_CR63","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/s0002-9394(14)70822-0","volume":"124","author":"MW Wilson","year":"1997","unstructured":"Wilson MW, Hungerford JL, George SM, Madreperla SA (1997) Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 124(3):303\u2013311. https:\/\/doi.org\/10.1016\/s0002-9394(14)70822-0. (Epub 1998\/01\/24.)","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4080_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/bjo.88.1.17","volume":"88","author":"C Chen","year":"2004","unstructured":"Chen C, Louis D, Dodd T, Muecke J (2004) Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol 88(1):17\u201318. https:\/\/doi.org\/10.1136\/bjo.88.1.17. (Epub 2003\/12\/25.)","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"4080_CR65","first-page":"55","volume":"12","author":"F Rahimi","year":"2009","unstructured":"Rahimi F, Alipour F, Ghazizadeh Hashemi H, Hashemian MN, Mehrdad R (2009) Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia. Arch Iran Med 12(1):55\u201359 (Epub 2008\/12\/30. PubMed PMID: 19111031.)","journal-title":"Arch Iran Med"},{"key":"4080_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-012-1931-x","author":"MB Kashkouli","year":"2012","unstructured":"Kashkouli MB, Heirati A, Pakdel F, Kiavash V, Naseripour M, Aghamohammadi F (2012) Long-term follow-up of invasive ocular surface squamous cell carcinoma treated with excision, cryotherapy, and topical Mitomycin C. Graefes Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-012-1931-x. (Epub 2012\/02\/03.)","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"4080_CR67","first-page":"1132","volume":"11","author":"A Rajeh","year":"2018","unstructured":"Rajeh A, Barakat F, Khurma S, AlRawashdeh K, Ababneh OH, AlNawaiseh I et al (2018) Characteristics, management, and outcome of squamous carcinoma of the conjunctiva in a single tertiary cancer center in Jordan. Intern J of Ophthalmol 11(7):1132\u20131138","journal-title":"Intern J of Ophthalmol"},{"key":"4080_CR68","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2147\/OPTH.S229399","volume":"13","author":"TR Elhamaky","year":"2019","unstructured":"Elhamaky TR, Elbarky AM (2019) AS-OCT guided treatment of diffuse conjunctival squamous cell carcinoma with resection, amniotic membrane graft and topical Mitomycin C. Clin Ophthalmol (Auckland, NZ) 13:2269\u20132278","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"6","key":"4080_CR69","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1016\/S2214-109X(16)30052-3","volume":"4","author":"S Gichuhi","year":"2016","unstructured":"Gichuhi S, Macharia E, Kabiru J, Zindamoyen AM, Rono H, Ollando E et al (2016) Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial. The Lancet Glob Heal 4(6):e378\u2013e385","journal-title":"The Lancet Glob Heal"},{"key":"4080_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtos.2022.12.002","volume":"27","author":"A Wylegala","year":"2023","unstructured":"Wylegala A, Sripawadkul W, Zein M, Alvarez OP, Al Bayyat G, Galor A et al (2023) Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study. The Ocul Surf 27:67\u201374","journal-title":"The Ocul Surf"},{"issue":"3","key":"4080_CR71","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/bjo.84.3.268","volume":"84","author":"E Midena","year":"2000","unstructured":"Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P (2000) Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. The Br J of Ophthalmol 84(3):268\u2013272","journal-title":"The Br J of Ophthalmol"},{"issue":"3","key":"4080_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/bjo.2010.183244","volume":"95","author":"R Parrozzani","year":"2011","unstructured":"Parrozzani R, Lazzarini D, Alemany-Rubio E, Urban F, Midena E (2011) Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study. The Br J of Ophthalmol 95(3):355\u2013359","journal-title":"The Br J of Ophthalmol"},{"issue":"7","key":"4080_CR73","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.ophtha.2016.02.034","volume":"123","author":"MG Joag","year":"2016","unstructured":"Joag MG, Sise A, Murillo JC, Sayed-Ahmed IO, Wong JR, Mercado C et al (2016) Topical 5-Fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmol 123(7):1442\u20131448","journal-title":"Ophthalmol"},{"issue":"8","key":"4080_CR74","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/bjophthalmol-2016-309219","volume":"101","author":"R Parrozzani","year":"2017","unstructured":"Parrozzani R, Frizziero L, Trainiti S, Testi I, Miglionico G, Pilotto E et al (2017) Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. The Br J of Ophthalmol 101(8):1094\u20131099","journal-title":"The Br J of Ophthalmol"},{"key":"4080_CR75","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jtos.2022.12.009","volume":"28","author":"W Sripawadkul","year":"2023","unstructured":"Sripawadkul W, Reyes-Capo D, Zein M, Wylegala A, Albayyat G, Galor A et al (2023) Long term study of topical interferon \u03b1-2b eye drops as primary treatment of ocular surface squamous neoplasia. Ocul Surf 28:108\u2013114. https:\/\/doi.org\/10.1016\/j.jtos.2022.12.009. (Epub 2023\/01\/03.)","journal-title":"Ocul Surf"},{"key":"4080_CR76","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2147\/OPTH.S9709","volume":"4","author":"A Al-Barrag","year":"2010","unstructured":"Al-Barrag A, Al-Shaer M, Al-Matary N, Al-Hamdani M (2010) 5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea. Clin Ophthalmol (Auckland, NZ) 4:801\u2013808","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"7","key":"4080_CR77","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/bjo.2010.186171","volume":"95","author":"AK Rudkin","year":"2011","unstructured":"Rudkin AK, Muecke JS (2011) Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia. The Br J of Ophthalmol 95(7):947\u2013950","journal-title":"The Br J of Ophthalmol"},{"issue":"7","key":"4080_CR78","first-page":"362","volume":"92","author":"E Ackuaku-Dogbe","year":"2015","unstructured":"Ackuaku-Dogbe E, Quaye B (2015) Management outcome of ocular surface conjunctival neoplasia. East Afr Med J 92(7):362\u2013365","journal-title":"East Afr Med J"},{"issue":"6","key":"4080_CR79","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/ICU.0b013e328010ab35","volume":"17","author":"F Mackensen","year":"2006","unstructured":"Mackensen F, Max R, Becker MD (2006) Interferon therapy for ocular disease. Curr Opin in Ophthalmol 17(6):567\u2013573","journal-title":"Curr Opin in Ophthalmol"},{"issue":"9","key":"4080_CR80","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.ophtha.2004.01.034","volume":"111","author":"MD Boehm","year":"2004","unstructured":"Boehm MD, Huang AJ (2004) Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmol 111(9):1755\u20131761. https:\/\/doi.org\/10.1016\/j.ophtha.2004.01.034. (Epub 2004\/09\/08. PubMed PMID: 15350333)","journal-title":"Ophthalmol"},{"key":"4080_CR81","doi-asserted-by":"crossref","unstructured":"Holcombe DJ, Lee GA (2006) Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. Am J Ophthalmol 142(4):568\u2013571","DOI":"10.1016\/j.ajo.2006.05.058"},{"issue":"8","key":"4080_CR82","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ophtha.2008.01.006","volume":"115","author":"A Sturges","year":"2008","unstructured":"Sturges A, Butt AL, Lai JE, Chodosh J (2008) Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmol 115(8):1297\u2013302. e1","journal-title":"Ophthalmol"},{"issue":"5","key":"4080_CR83","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/bjo.2008.153197","volume":"94","author":"A Galor","year":"2010","unstructured":"Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC (2010) Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol 94(5):551\u2013554. https:\/\/doi.org\/10.1136\/bjo.2008.153197","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4080_CR84","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archophthalmol.2011.385","volume":"130","author":"SU Shah","year":"2012","unstructured":"Shah SU, Kaliki S, Kim HJ, Lally SE, Shields JA, Shields CL (2012) Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Arch of Ophthalmol (Chicago, Ill\u202f: 1960) 130(2):159\u2013164. https:\/\/doi.org\/10.1001\/archophthalmol.2011.385. (Epub 2012\/02\/15. PubMed PMID: 22332208)","journal-title":"Arch of Ophthalmol (Chicago, Ill : 1960)"},{"issue":"6","key":"4080_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/jop.2013.0084","volume":"30","author":"JE Mu\u00f1oz de Escalona Rojas","year":"2014","unstructured":"Mu\u00f1oz de Escalona Rojas JE, Garc\u00eda Serrano JL, Cantero Hinojosa J, Padilla Torres JF, Bellido Mu\u00f1oz RM (2014) Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors. J Ocul Pharmacol Ther 30(6):489\u2013494. https:\/\/doi.org\/10.1089\/jop.2013.0084","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"4080_CR86","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/apo.0000000000000104","volume":"4","author":"R Kusumesh","year":"2015","unstructured":"Kusumesh R, Ambastha A, Sinha B, Kumar R (2015) Topical interferon \u03b1-2b as a single therapy for primary ocular surface squamous neoplasia. Asia-Pacific J of Ophthalmol (Philadelphia, Pa) 4(5):279\u2013282. https:\/\/doi.org\/10.1097\/apo.0000000000000104","journal-title":"Asia-Pacific J of Ophthalmol (Philadelphia, Pa)"},{"issue":"7-8","key":"4080_CR87","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/08820538.2019.1648691","volume":"34","author":"S Kaliki","year":"2019","unstructured":"Kaliki S, Bejjanki KM, Desai A, Mohamed A (2019) Interferon Alfa 2b for ocular surface squamous neoplasia: factors influencing the treatment response. Semin Ophthalmol 34(7\u20138):465\u2013472. https:\/\/doi.org\/10.1080\/08820538.2019.1648691. (Epub 2019\/08\/03. PubMed PMID: 31370766)","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"4080_CR88","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4103\/2452-2325.329089","volume":"33","author":"R Ghaffari","year":"2021","unstructured":"Ghaffari R, Barijani S, Alivand A, Latifi G, Ghassemi H, Zarei-Ghanavati M et al (2021) Recombinant interferon Alpha-2b as primary treatment for ocular surface squamous neoplasia. J Curr Ophthalmol 33(3):260\u2013265. https:\/\/doi.org\/10.4103\/2452-2325.329089","journal-title":"J Curr Ophthalmol"},{"issue":"3","key":"4080_CR89","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4103\/ijo.IJO_1665_20","volume":"69","author":"CL Shields","year":"2021","unstructured":"Shields CL, Constantinescu AB, Paulose SA, Yaghy A, Dalvin LA, Shields JA et al (2021) Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: comparative analysis of outcomes based on original tumor configuration. Indian J Ophthalmol 69(3):563\u2013567. https:\/\/doi.org\/10.4103\/ijo.IJO_1665_20","journal-title":"Indian J Ophthalmol"},{"key":"4080_CR90","doi-asserted-by":"crossref","unstructured":"Huerva V, Vilaltella M (2021) Ocular surface squamous neoplasia resistant to topical interferon alpha 2b in a patient with follicular lymphoma. Int J Ophthalmol 14(7):1122","DOI":"10.18240\/ijo.2021.07.24"},{"key":"4080_CR91","doi-asserted-by":"crossref","unstructured":"Sripawadkul W, Reyes-Capo D, Zein M, Wylegala A, Albayyat G, Galor A, Karp CL (2023) Long term study of topical interferon \u03b1-2b eye drops as primary treatment of ocular surface squamous neoplasia. The Ocular Surface 28:108\u2013114","DOI":"10.1016\/j.jtos.2022.12.009"},{"issue":"2","key":"4080_CR92","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5935\/0004-2749.20220018","volume":"85","author":"M Vilaltella","year":"2021","unstructured":"Vilaltella M, Huerva V (2021) The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size. Arq Bras Oftalmol 85(2):109\u2013114. https:\/\/doi.org\/10.5935\/0004-2749.20220018. (Epub 2021\/08\/26. PubMed PMID: 34431893)","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"4080_CR93","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/jir.2018.0125","volume":"39","author":"N Lewczuk","year":"2019","unstructured":"Lewczuk N, Zdebik A, Bogus\u0142awska J (2019) Interferon Alpha 2a and 2b in ophthalmology: a review. J Interferon Cytokine Res 39(5):259\u2013272. https:\/\/doi.org\/10.1089\/jir.2018.0125. (Epub 2019\/04\/06.)","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"4080_CR94","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-025-03465-x","volume":"45","author":"K Bakal","year":"2025","unstructured":"Bakal K, Gupta A, Kaliki S (2025) Interferon alpha-2b versus 5-fluorouracil as primary treatment modalities for ocular surface squamous neoplasia: a study of 116 eyes. Int Ophthalmol 45(1):87. https:\/\/doi.org\/10.1007\/s10792-025-03465-x","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4080_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-024-03105-w","volume":"44","author":"JJ San Rom\u00e1n Llorens","year":"2024","unstructured":"San Rom\u00e1n Llorens JJ, Fern\u00e1ndez-Gurria M, Artaechevarria Artieda J, Alejandre Alba N, Garc\u00eda Sandoval B, Jim\u00e9nez-Alfaro Morote I (2024) Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon \u03b1-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital. Int Ophthalmol 44(1):184. https:\/\/doi.org\/10.1007\/s10792-024-03105-w","journal-title":"Int Ophthalmol"},{"key":"4080_CR96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ajo.2018.11.007","volume":"199","author":"N Venkateswaran","year":"2019","unstructured":"Venkateswaran N, Mercado C, Galor A, Karp CL (2019) Comparison of topical 5-Fluorouracil and Interferon Alfa-2b as primary treatment modalities for ocular surface squamous neoplasia. Am J Ophthalmol 199:216\u2013222. https:\/\/doi.org\/10.1016\/j.ajo.2018.11.007","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4080_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18545-6","volume":"12","author":"K Kozma","year":"2022","unstructured":"Kozma K, D\u00f6m\u00f6t\u00f6r ZR, Csutak A, Szab\u00f3 L, Hegyi P, Er\u0151ss B et al (2022) Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis. Sci Rep 12(1):14221. https:\/\/doi.org\/10.1038\/s41598-022-18545-6. (Epub 2022\/08\/21.)","journal-title":"Sci Rep"},{"issue":"1","key":"4080_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-019-0150-5","volume":"6","author":"G Al Bayyat","year":"2019","unstructured":"Al Bayyat G, Arreaza-Kaufman D, Venkateswaran N, Galor A, Karp CL (2019) Update on pharmacotherapy for ocular surface squamous neoplasia. Eye and vision (London, England) 6(1):24. https:\/\/doi.org\/10.1186\/s40662-019-0150-5","journal-title":"Eye and vision (London, England)"},{"issue":"2","key":"4080_CR99","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1177\/11206721211014376","volume":"32","author":"R Meel","year":"2022","unstructured":"Meel R, Dhiman R, Kashyap S, Agrawal S, Pushker N, Bakhshi S (2022) Systemic neoadjuvant chemotherapy in non-resectable invasive squamous cell carcinoma of ocular surface. Eur J Ophthalmol 32(2):1205\u20131210","journal-title":"Eur J Ophthalmol"},{"key":"4080_CR100","first-page":"85","volume":"52","author":"ME Aronow","year":"2013","unstructured":"Aronow ME, Singh AD (2013) Radiation therapy: conjunctival and eyelid tumors. Dev in Ophthalmol 52:85\u201393","journal-title":"Dev in Ophthalmol"},{"issue":"5","key":"4080_CR101","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/ico.0000000000000766","volume":"35","author":"AN Siedlecki","year":"2016","unstructured":"Siedlecki AN, Tapp S, Tosteson AN, Larson RJ, Karp CL, Lietman T et al (2016) Surgery versus Interferon Alpha-2b treatment strategies for ocular surface squamous neoplasia: a literature-based decision analysis. Cornea 35(5):613\u2013618. https:\/\/doi.org\/10.1097\/ico.0000000000000766. (Epub 2016\/02\/19.)","journal-title":"Cornea"},{"key":"4080_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010713","author":"CHY Yeoh","year":"2022","unstructured":"Yeoh CHY, Lee JJR, Lim BXH, Sundar G, Mehta JS, Chan ASY et al (2022) The management of ocular surface squamous neoplasia (OSSN). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010713. (Epub 2023\/01\/09.)","journal-title":"Int J Mol Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04080-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:34:51Z","timestamp":1777361691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04080-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4080"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04080-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"212"}}